We are live on ! Find out more
DA

DSC Advisors Portfolio holdings

AUM $11M
1-Year Est. Return 5.88%
This Fund
S&P 500
This Quarter Est. Return
+8.39%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$544M
AUM Growth
-$282M
Cap. Flow
-$349M
Cap. Flow %
-64.13%
Top 10 Hldgs %
79.89%
Holding
92
New
22
Increased
24
Reduced
24
Closed
15

Sector Composition

1 Financials 10.88%
2 Healthcare 9.71%
3 Communication Services 4.67%
4 Materials 2.47%
5 Industrials 2.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$232M 42.57%
820,000
-1,180,000
-59% -$321M
IEF icon
2
PUT
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
$92.4M 16.97%
865,800
ATH
3
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$22.6M 4.15%
553,921
MS icon
4
Morgan Stanley
MS
$343B
$18.3M 3.37%
434,746
-61
-0% -$2.57K
GOOG icon
5
Alphabet (Google) Class C
GOOG
$4.32T
$13.5M 2.48%
230,000
BERY
6
DELISTED
Berry Global Group, Inc.
BERY
$13.5M 2.48%
272,250
-5,445
-2% -$258K
JPM icon
7
JPMorgan Chase
JPM
$912B
$11.9M 2.19%
117,860
-159
-0.1% -$16.4K
DAL icon
8
Delta Air Lines
DAL
$57B
$10.8M 1.99%
210,000
-25,000
-11% -$1.24M
ZBH icon
9
Zimmer Biomet
ZBH
$18.1B
$10.2M 1.87%
82,198
+22,686
+38% +$2.58M
CVS icon
10
CVS Health
CVS
$136B
$9.86M 1.81%
182,787
+70,009
+62% +$4.32M
QQQ icon
11
CALL
Invesco QQQ Trust
QQQ
$466B
$8.98M 1.65%
+50,000
New +$8.48M
PARA
12
DELISTED
Paramount Global Class B
PARA
$7.84M 1.44%
165,000
+25,000
+18% +$1.22M
FOMX
13
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$7.27M 1.34%
+1,937,724
New +$7.26M
COR icon
14
Cencora
COR
$59.9B
$6.96M 1.28%
87,500
+20,000
+30% +$1.61M
ZVRA icon
15
Zevra Therapeutics
ZVRA
$754M
$6.84M 1.26%
255,995
ALXN
16
DELISTED
Alexion Pharmaceuticals
ALXN
$6.08M 1.12%
45,000
-10,000
-18% -$1.24M
SPY icon
17
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$5.65M 1.04%
+20,000
New +$5.43M
XLF icon
18
CALL
State Street Financial Select Sector SPDR ETF
XLF
$54.8B
$5.14M 0.94%
+200,000
New +$5.16M
IYR icon
19
PUT
iShares US Real Estate ETF
IYR
$4.83B
$4.35M 0.8%
+50,000
New +$4.13M
DVA icon
20
DaVita
DVA
$15B
$4.07M 0.75%
+75,000
New +$4.15M
IFF icon
21
PUT
International Flavors & Fragrances
IFF
$19.8B
$3.86M 0.71%
+30,000
New +$3.98M
XLU icon
22
PUT
State Street Utilities Select Sector SPDR ETF
XLU
$23.5B
$2.91M 0.53%
+100,000
New +$2.78M
DFS
23
DELISTED
Discover Financial Services
DFS
$2.7M 0.5%
38,000
GDX icon
24
CALL
VanEck Gold Miners ETF
GDX
$21.8B
$2.24M 0.41%
100,000
MSFT icon
25
Microsoft
MSFT
$2.98T
$1.64M 0.3%
13,931
+1,126
+9% +$123K

Similar funds

DSC Advisors's Q1 2019 Portfolio in Review

As of Q1 2019, DSC Advisors held 92 positions worth $544M, down 34% from $826M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

DSC Advisors withdrew a net $349M in Q1 2019, closing 15 positions and reducing 24 holdings. Its most notable exit was HCA Healthcare, an estimated $20M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 6.7% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, DSC Advisors opened a new position in Foamix Pharmaceuticals Ltd. Ordinary Shares worth $7.27M.

  • DSC Advisors's largest Q1 2019 buy was Foamix Pharmaceuticals Ltd. Ordinary Shares: 1,937,724 shares worth $7.27M.
  • DSC Advisors added most to CVS Health in Q1 2019, an estimated $4.32M increase.
  • DSC Advisors's biggest Q1 2019 reduction was Alexion Pharmaceuticals, cutting an estimated $1.24M.
  • DSC Advisors fully exited HCA Healthcare in Q1 2019, selling an estimated $20M.
  • DSC Advisors's ten largest holdings make up 80% of its $544M portfolio in Q1 2019.
  • DSC Advisors opened 22 new positions and closed 15 in Q1 2019.
  • DSC Advisors's portfolio value fell 34% quarter-over-quarter to $544M.

Based on DSC Advisors's 13F filing for Q1 2019, filed 15 May 2019.